Home » Newsletters » BioWorld Science

BioWorld Science

April 8, 2015

View Archived Issues

Constellation Pharmaceuticals tests EZH2 inhibitor in patients with B-cell lymphoma

German scientists report development of bi- or multispecific antibodies

rHuCat-L shows promising results for the treatment of cellulite

State University of New York patents novel dendrimer-drug conjugates

Ocular Therapeutix reports results from second phase III trial of dexamethasone punctal plug

New OX2R antagonist shows potential for the treatment of insomnia

sGC activators prevent progression of diabetic nephropathy

Nabriva Therapeutics raises funds to advance new class of antibiotic

Repros' enclomiphene eligible for new active substance status

PCI Biotech begins preclinical research collaboration in siRNA therapeutics

Scripps receives grant to develop treatments for intellectual disability, autism, epilepsy

BIND Therapeutics extends global collaboration with Pfizer to develop multiple Accurins

Carna Biosciences patents novel BTK inhibitors

Karyopharm Therapeutics discloses PAK inhibitors

Alios BioPharma develops new antivirals

GlaxoSmithKline describes novel inhibitors of RIP-1 and RIP-2 kinases

Targeting IRS proteins presented as a new approach for prostate cancer therapy

Sanofi Pasteur to use VBI Vaccines' lipid particle vaccine technology

GlaxoSmithKline's SARM for muscle wasting diseases

Gilead Sciences files NDA for emtricitabine/tenofovir alafenamide combination for HIV infection

Analysis of HLA genes links genotypes to risk of atherosclerosis in patients with psoriasis

TaxusCardium licenses ASEAN and Latin American rights to Generx to Dr Reddy's

Celtaxsys to start phase II trial of oral CTX-4430 in acne vulgaris

AmorChem invests in Canada's Personalized Cancer Immunotherapy Program

Cytori Therapeutics' ECCS-50 receives E.U. orphan drug designation for scleroderma

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...